Nordic colorectal cancer screening programmes: A comparison of organization, operation, and quality indicators

IF 7.6 1区 医学 Q1 ONCOLOGY
Susanne Fogh Jørgensen , Sisse Helle Njor , Aapeli Nevala , Birger Pålsson , Kristin Ranheim Randel , Ágúst Ingi Ágústsson , Tytti Sarkeala , Anna Lisa Schult , Rikard Svernlöv , Helgi Birgisson , The Nordic Colorectal cancer Screening Network
{"title":"Nordic colorectal cancer screening programmes: A comparison of organization, operation, and quality indicators","authors":"Susanne Fogh Jørgensen ,&nbsp;Sisse Helle Njor ,&nbsp;Aapeli Nevala ,&nbsp;Birger Pålsson ,&nbsp;Kristin Ranheim Randel ,&nbsp;Ágúst Ingi Ágústsson ,&nbsp;Tytti Sarkeala ,&nbsp;Anna Lisa Schult ,&nbsp;Rikard Svernlöv ,&nbsp;Helgi Birgisson ,&nbsp;The Nordic Colorectal cancer Screening Network","doi":"10.1016/j.ejca.2025.115444","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>While comparison studies are common in the Nordic countries, important differences need to be illuminated to understand the comparability of future studies within colorectal cancer (CRC) screening research.</div><div>Therefore, a systematic overview of similarities and differences in the CRC screening programmes in Denmark, Finland, Iceland, Norway, and Sweden was conducted</div></div><div><h3>Methods</h3><div>Information from each country was gathered through the Nordic CRC screening network, which includes experts in CRC screening from the participating countries.</div><div>A timeline describing preceding pilot studies and national roll-outs in all countries was established. Furthermore, the screening flow in each country and the quality indicator monitoring including performance standards were presented.</div></div><div><h3>Results</h3><div>During 2014–2024, all five Nordic countries implemented CRC screening using faecal immunochemical testing (FIT) but with different implementation strategies and cut-off values. Taking colonoscopy resources into account, gradual implementation strategies were used in all countries, but with different paces. Quality monitoring follows the European recommendations with some variation; however key performance indicators such as adenoma detection rates (ADR), colonoscopy complication rates, serrated polyp detection, post-colonoscopy CRC (PCCRC) rates, and interval cancer rates, are monitored by all countries.</div></div><div><h3>Conclusion</h3><div>This paper may serve as a key reference for future research and comparison studies across the Nordic countries. The variation found in countries with similar health care systems might serve as natural experiments in future studies. Furthermore, this overview shows that there might be room for improvements in the monitoring of certain quality indicators to facilitate quality improvement efforts in all Nordic countries.</div></div>","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"222 ","pages":"Article 115444"},"PeriodicalIF":7.6000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0959804925002254","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

While comparison studies are common in the Nordic countries, important differences need to be illuminated to understand the comparability of future studies within colorectal cancer (CRC) screening research.
Therefore, a systematic overview of similarities and differences in the CRC screening programmes in Denmark, Finland, Iceland, Norway, and Sweden was conducted

Methods

Information from each country was gathered through the Nordic CRC screening network, which includes experts in CRC screening from the participating countries.
A timeline describing preceding pilot studies and national roll-outs in all countries was established. Furthermore, the screening flow in each country and the quality indicator monitoring including performance standards were presented.

Results

During 2014–2024, all five Nordic countries implemented CRC screening using faecal immunochemical testing (FIT) but with different implementation strategies and cut-off values. Taking colonoscopy resources into account, gradual implementation strategies were used in all countries, but with different paces. Quality monitoring follows the European recommendations with some variation; however key performance indicators such as adenoma detection rates (ADR), colonoscopy complication rates, serrated polyp detection, post-colonoscopy CRC (PCCRC) rates, and interval cancer rates, are monitored by all countries.

Conclusion

This paper may serve as a key reference for future research and comparison studies across the Nordic countries. The variation found in countries with similar health care systems might serve as natural experiments in future studies. Furthermore, this overview shows that there might be room for improvements in the monitoring of certain quality indicators to facilitate quality improvement efforts in all Nordic countries.
北欧结直肠癌筛查项目:组织、操作和质量指标的比较
虽然比较研究在北欧国家很常见,但需要阐明重要的差异,以了解结直肠癌(CRC)筛查研究中未来研究的可比性。因此,我们对丹麦、芬兰、冰岛、挪威和瑞典的CRC筛查计划的异同进行了系统的概述。方法通过北欧CRC筛查网络收集来自每个国家的信息,该网络包括来自参与国的CRC筛查专家。制定了描述以往试点研究和在所有国家推广的时间表。此外,还介绍了各国的筛选流程和包括绩效标准在内的质量指标监测。结果2014-2024年,北欧5个国家均采用粪便免疫化学检测(FIT)实施结直肠癌筛查,但实施策略和临界值不同。考虑到结肠镜检查资源,所有国家都采用了渐进式实施策略,但速度不同。质量监测遵循欧洲的建议,但有一些差异;然而,所有国家都监测关键绩效指标,如腺瘤检出率(ADR)、结肠镜检查并发症率、锯齿状息肉检出率、结肠镜检查后CRC (PCCRC)率和间隔期癌症率。结论本研究可为今后北欧国家间的研究和比较提供重要参考。在卫生保健系统相似的国家中发现的差异可能作为未来研究的自然实验。此外,这一概述表明,在监测某些质量指标方面可能有改进的余地,以促进所有北欧国家的质量改进工作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Cancer
European Journal of Cancer 医学-肿瘤学
CiteScore
11.50
自引率
4.80%
发文量
953
审稿时长
23 days
期刊介绍: The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信